Trending Now
AnPac Bio-Medical Science Co Ltd (NASDAQ: ANPC) Receive Letter From the...
AnPac Bio-Medical Science Co Ltd (NASDAQ: ANPC) announced that the Nasdaq Stock Department LLC's Listing Qualifications Department sent a staff determination letter...
DIH Holding US, Inc. (DHAI): Pioneering Rehabilitation with Cutting-Edge Technology
Let’s talk about something truly inspiring: the future of rehabilitation. On December 23, 2024, DIH Holding US, Inc. (NASDAQ: DHAI) announced...
Predictive Oncology Inc. (Nasdaq: POAI): A Transformative Acquisition by Renovaro Inc.
The biotechnological domain is currently abuzz with developments surrounding the acquisition of Predictive Oncology Inc. (Nasdaq: POAI) by Renovaro Inc. (Nasdaq: RENB)....
Popular News
Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) Enters Commercialization Agreement with Otsuka Pharmaceuticals for...
Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) has announced the signing of a collaboration and license agreement with Otsuka Pharmaceutical Co. Ltd. The agreement is...
MAKE IT MODERN
LATEST REVIEWS
Mustang Bio Inc. (NASDAQ:MBIO) Receives Orphan Drug Designation For MB-207 in...
Mustang Bio Inc. (NASDAQ:MBIO) has been awarded Orphan Drug Designation for MB-207, its lentiviral gene therapy for treating patients with X-linked severe combined immunodeficiency...
MAKE IT MODERN
PERFORMANCE TRAINING
Vericel Corp (NASDAQ:VCEL) Expect To Record Net Revenues Of $20 Million In Q2 2020
Vericel Corp (NASDAQ:VCEL) expects to report a drop of 23% in Q2 2020 revenues to $20 million. Net revenues of MACI and Epicel, the...
Stocks Set to Confront the Virus in 2021 (MRNA, HALB, PFE)
For investors, economic data is contingent entirely on the concept of measures that undermine the negative impact of COVID-19. For households, businesses,...
Rolls-Royce (RYCEY) shares gain double digits post annual results
Rolls-Royce (OTCMKTS:RYCEY) shares rose by 23% on Thursday after the aviation manufacturer reported a 57% YoY increase in underlying profit for 2022,...
Catabasis Pharmaceuticals Inc. (NASDAQ:CATB) Release Q3 2020 Financial and Operational Results As It Considers...
Catabasis Pharmaceuticals Inc. (NASDAQ:CATB) has announced its results and provided a business update for the three months ended September 30, 2020.
PolarisDMD edasalonexent study failed...
ARCA Biopharma Inc. (NASDAQ:ABIO) Is Developing AB201Program As A Possible COVID-19 Treatment
ARCA Biopharma Inc. (NASDAQ:ABIO) is developing a new program for evaluating AB201 (rNAPc2). It is a selective tissue factor inhibitor for treating coronavirus related...
MAKE IT MODERN
